Properties of the Surface Envelope Glycoprotein Associated with Virulence of Simian-Human Immunodeficiency Virus SHIV SF33A Molecular Clones
- 15 February 2002
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (4) , 1588-99
- https://doi.org/10.1128/jvi.76.4.1588-1599.2002
Abstract
In vivo adaptation of simian-human immunodeficiency virus (SHIV) clone SHIV SF33 resulted in the emergence of pathogenic isolate SHIV SF33A , which caused a rapid and severe CD4 + T-cell depletion when inoculated into rhesus macaques. Two molecular clones generated by inserting the env V1-to-V5 region amplified from SHIV SF33A -infected animals into the parental SHIV SF33 genome retained a pathogenic phenotype. The gp120 envelope glycoproteins of pathogenic clones SHIV SF33A2 and SHIV SF33A5 conferred a threefold increase in viral entry and fusogenicity compared to the parental glycoprotein. Changes in gp120 were also responsible for a higher replication capacity and cytopathicity in primary CD4 + T-cell cultures. Last, gp120 carried the determinants of SHIV SF33A neutralization resistance. Thus, changes in SHIV SF33A gp120 produced a set of properties that could account for the pathogenic phenotype observed in vivo. Measurement of antibody binding to SHIV SF33A viral particles revealed an increased exposure of the CD4-induced epitope recognized by the 17b monoclonal antibody in a region that was shown to contribute to coreceptor binding. Exposure of this epitope occurred in the absence of CD4 binding, suggesting that the envelope glycoprotein of pathogenic SHIV SF33A clones folded in a conformation that was primed for interaction with CXCR4 or for the subsequent step of fusion.Keywords
This publication has 51 references indexed in Scilit:
- Pathogenic Determinants of the Mucosally Transmissible CXCR4-Specific SHIV SF33A2 Map to env RegionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Membrane-Fusing Capacity of the Human Immunodeficiency Virus Envelope Proteins Determines the Efficiency of CD4+T-Cell Depletion in Macaques Infected by a Simian-Human Immunodeficiency VirusJournal of Virology, 2001
- Determination of Essential Amino Acids Involved in the CD4-Independent Tropism of the X4 Human Immunodeficiency Virus Type 1 m7NDK Isolate: Role of Potential N Glycosylations in the C2 and V3 Regions of gp120Journal of Virology, 2001
- Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope ProteinJournal of Virology, 2001
- Envelope Glycoprotein Determinants of Neutralization Resistance in a Simian-Human Immunodeficiency Virus (SHIV-HXBc2P 3.2) Derived by Passage in MonkeysJournal of Virology, 2001
- Differential CD4/CCR5 Utilization, gp120 Conformation, and Neutralization Sensitivity between Envelopes from a Microglia-Adapted Human Immunodeficiency Virus Type 1 and Its Parental IsolateJournal of Virology, 2001
- Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus VariantsJournal of Virology, 2001
- Critical Role of Enhanced CD4 Affinity in Laboratory Adaptation of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 2000
- Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.The Journal of Experimental Medicine, 1996
- Fusion mutants of the influenza virus hemagglutinin glycoproteinCell, 1985